Who’s really in charge at Anthropic after the IPO?
- ID
- 40169
- Status
- summarized
- Published
- 28 Oct 2026, 5:38 AM
- Fetched
- 28 Oct 2026, 6:08 AM
- Provider
- TechCrunch
- Category
- technology
- Original URL
- https://techcrunch.com/2026/10/27/whos-really-in-charge-at-anthropic-after-the-ipo/
- Source URL
- https://techcrunch.com/feed/
Summary
- Score
- 5.0
- Created
- 28 Oct 2026, 6:09 AM
- Tags
- Audience
- foundersai_ml_learners
What happened
Ahead of its IPO, Anthropic's governance gives public common shareholders almost no say: it is a public benefit corporation whose board is chaired by president Daniela Amodei and includes CEO Dario Amodei, Reed Hastings, Christopher Liddell, Vas Narasimhan and Yasmin Razavi, with one vacancy. A Long Term Benefit Trust (LTBT) — chaired by Neil Shah and including Ben Bernanke, Richard Fontaine and Christopher Stubbs, also with one vacancy — owns a Class T stock that can elect and remove a majority of the board. TechCrunch frames this as a deliberately baroque structure that shuts ordinary buyers of the stock out of major decisions, including board seats.
Why it matters
If you plan to buy Anthropic stock at IPO, or pitch your own company as mission-locked, this is a concrete data point: Class T stock lets the LTBT elect and remove a board majority regardless of what public shareholders own or vote. Decide whether you treat that as durability for an API vendor you build on, or as a reason to avoid the equity and keep your dependency at the API-contract level rather than the cap table. Nothing here changes Claude pricing, model access or developer terms.
Discussion angle
Would you copy the Class T trust structure for your own startup to protect a mission, or does it make the IPO uninvestable for ordinary shareholders — and does that change how much of your product you're willing to build on one vendor's API?